Metabolic physiopathology

Publications (419)

Publication Search

Naudí A; Cabré R; Jové M; Ayala V; Gonzalo H; Portero-Otín M; Ferrer I; Pamplona R

Lipidomics of Human Brain Aging and Alzheimer's Disease Pathology

International Review of Neurobiology 122 133-189. .

[doi:10.1016/bs.irn.2015.05.008]

Gomez, A.; Gomez, J.; Torres, M.L.; Naudi, A.; Mota-Martorell, N.; Pamplona, R.; Barja, G.

Cysteine dietary supplementation reverses the decrease in mitochondrial ROS production at complex I induced by methionine restriction

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES 47 199-208. .

[doi:10.1007/s10863-015-9608-x]

Ost M; Keipert S; van Schothorst EM; Donner V; van der Stelt I; Kipp AP; Petzke KJ; Jove M; Pamplona R; Portero-Otin M; Keijer J; Klaus S

Muscle mitohormesis promotes cellular survival via serine/glycine pathway flux

FASEB JOURNAL 29 1314-1328. .

[doi:10.1096/fj.14-261503]

López-González I; Schlüter A; Aso E; Garcia-Esparcia P; Ansoleaga B; LLorens F; Carmona M; Moreno J; Fuso A; Portero-Otin M; Pamplona R; Pujol A; Ferrer I

Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice: Correlations With Plaques, Tangles, and Oligomeric Species

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 74 319-344. .

[doi:10.1097/NEN.0000000000000176]

Purroy, F; Jove, M; Portero, M; Cambray, S; Suarez, I; Sanahuja, J; Farre, J; Benabdelhak, I

Metabolomics discriminate etiologic subtypes among TIA patients

International Journal of Stroke 10 222-222. .

Jové M; Mauri-Capdevila G; Suárez I; Cambray S; Sanahuja J; Quílez A; Farré J; Benabdelhak I; Pamplona R; Portero-Otín M; Purroy F

Metabolomics predicts stroke recurrence after transient ischemic attack

NEUROLOGY 84 36-45. .

[doi:10.1212/WNL.0000000000001093]

Ansoleaga B; Jové M; Schlüter A; Garcia-Esparcia P; Moreno J; Pujol A; Pamplona R; Portero-Otín M; Ferrer I

Deregulation of purine metabolism in Alzheimer's disease

NEUROBIOLOGY OF AGING 36 68-80. .

[doi:10.1016/j.neurobiolaging.2014.08.004]

Espinet C; Gonzalo H; Fleitas C; Menal MJ; Egea J

Oxidative Stress and Neurodegenerative Diseases: A Neurotrophic Approach

CURRENT DRUG TARGETS 16 20-30. .

[doi:10.2174/1389450116666150107153233]

Cacabelos, D.; Ayala, V.; Ramírez-Nunez, O.; Granado-Serrano, A.B.; Boada, J.; Serrano, J.C.E.; Cabré, R.; Nadal-Rey, G.; Bellmunt, M.J.; Ferrer, I.; Pamplona, R.; Portero-Otin, M.

Dietary Lipid Unsaturation Influences Survival and Oxidative Modifications of an Amyotrophic Lateral Sclerosis Model in a Gender-Specific Manner

NEUROMOLECULAR MEDICINE 16 669-685. .

[doi:10.1007/s12017-014-8317-7]

Jové M; Naudí A; Portero-Otin M; Cabré R; Rovira-Llopis S; Bañuls C; Rocha M; Hernández-Mijares A; Victor VM; Pamplona R

Plasma lipidomics discloses metabolic syndrome with a specific HDL phenotype

FASEB JOURNAL 28 5163-5171. .

[doi:10.1096/fj.14-253187]

Jove M; Maslanka M; Minkowitz HS; Jaffer AK

Safety of Desirudin in Thrombosis Prevention After Total Knee Arthroplasty: The DESIR-ABLE Study

AMERICAN JOURNAL OF THERAPEUTICS 21 496-499. .

[doi:10.1097/MJT.0b013e3182691778]

Blasco G; Puig J; Daunis-I-Estadella J; Molina X; Xifra G; Fernández-Aranda F; Pedraza S; Ricart W; Portero-Otín M; Fernández-Real JM

Brain Iron Overload, Insulin Resistance, and Cognitive Performance in Obese Subjects: A Preliminary MRI Case-Control Study

DIABETES CARE 37 3076-3083. .

[doi:10.2337/dc14-0664]